Search Results

0 results for 'Vedder Price'

You can use to get even better search results
July 01, 2008 |

THE A-LIST 2008: 51-200

24 minute read
Wander v St. John's Univ.
Publication Date: 2009-11-17
Practice Area:
Industry:
Court: Appellate Division, 2nd Dept
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number: 2009-02309

Supreme Court of the State of New York Appellate Division: Second Judicial Department STEVEN W. FISHER, J.P. ANITA R. FLORIO RANDALL T. ENG SHERI S. ROMA

August 18, 2003 |

The March Goes On

Wolf, Block is merging with Roseland's 53-lawyer Brach, Eichler, emerging as the third large Philadelphia firm to become a major player in New Jersey through acquisition. The move exemplifies the cross-border trend begun in the late 1980s, as multistate firms push into the state's lucrative market to stay competitive.
7 minute read
Guess Who's On the Winning Side in the Latest Novartis Employment Loss?
Publication Date: 2010-07-07
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

On Tuesday the Second Circuit ruled that the pharmaceutical company is on the hook for overtime for 2,700 sales reps in three wage-and-hour class actions. For Novartis, the lawyers representing the plaintiffs are all too familiar.

October 01, 2009 |

The Local Talent: Results by City

32 minute read
July 01, 2013 |

Arbitration Scorecard 2013: Treaty Disputes

Treaty arbitrations active in 2011–13 in which at least $100 million was at stake.
55 minute read
November 19, 2007 |

Results by City

44 minute read
February 01, 2007 |

PRO BONO SCORECARD 2007: Scoring the Firms

26 minute read
As Supreme Court Mulls Overtime for Pharma Sales Reps, Novartis Settles Class Action for $99 Million
Publication Date: 2012-01-25
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

If the Supreme Court rules later this year that pharmaceutical sales representatives are exempt from overtime requirements of the Fair Labor Standards Act, the high court could knock out class action wage-and-hour claims pending against a half-dozen major drug companies. But Novartis and its lawyers at Cravath apparently weren't willing to gamble that the Justices would see things the drug companies' way.

May 30, 2008 |

The A-List (51-200)

Lawyers like to lament the passing of their fabled past, when partners knew each other on sight, firms contented themselves to operating in one ZIP code and junior associates were not a menacing anonymous horde threatening to take out their frustrations via the blogosphere. As it happens, in the big-firm world those days aren't gone, they've just moved to the Am Law Second Hundred ranks, where firms are prosperous and growing steadily but retain the possibility of old-fashioned cohesion.
28 minute read

Resources

  • Good Legal Technology is Good Business: A Case for Bringing Employment Issues In-House

    Brought to you by LexisNexis®

    Download Now

  • Insights and Strategies for Effective Succession Planning in AM Law 100 Firms

    Brought to you by Gallagher

    Download Now

  • State AI Legislation Is on the Move in 2024

    Brought to you by LexisNexis®

    Download Now

  • 2024 ESI Risk Management & Litigation Readiness Report

    Brought to you by Pagefreezer

    Download Now

NEXT